Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Breast Cancer Suppression by Progesterone Receptors Is Mediated by Their Modulation of Estrogen Receptors and RNA Polymerase III.

Finlay-Schultz J, Gillen AE, Brechbuhl HM, Ivie JJ, Matthews SB, Jacobsen BM, Bentley DL, Kabos P, Sartorius CA.

Cancer Res. 2017 Sep 15;77(18):4934-4946. doi: 10.1158/0008-5472.CAN-16-3541. Epub 2017 Jul 20.

2.

Cross talk between progesterone receptors and retinoic acid receptors in regulation of cytokeratin 5-positive breast cancer cells.

Fettig LM, McGinn O, Finlay-Schultz J, LaBarbera DV, Nordeen SK, Sartorius CA.

Oncogene. 2017 Nov 2;36(44):6074-6084. doi: 10.1038/onc.2017.204. Epub 2017 Jul 10.

3.

The glucose transporter GLUT1 is required for ErbB2-induced mammary tumorigenesis.

Wellberg EA, Johnson S, Finlay-Schultz J, Lewis AS, Terrell KL, Sartorius CA, Abel ED, Muller WJ, Anderson SM.

Breast Cancer Res. 2016 Dec 20;18(1):131. doi: 10.1186/s13058-016-0795-0.

4.

Labeling of Breast Cancer Patient-derived Xenografts with Traceable Reporters for Tumor Growth and Metastasis Studies.

Hanna C, Kwok L, Finlay-Schultz J, Sartorius CA, Cittelly DM.

J Vis Exp. 2016 Nov 30;(117). doi: 10.3791/54944.

5.

Fibroblast Subtypes Regulate Responsiveness of Luminal Breast Cancer to Estrogen.

Brechbuhl HM, Finlay-Schultz J, Yamamoto TM, Gillen AE, Cittelly DM, Tan AC, Sams SB, Pillai MM, Elias AD, Robinson WA, Sartorius CA, Kabos P.

Clin Cancer Res. 2017 Apr 1;23(7):1710-1721. doi: 10.1158/1078-0432.CCR-15-2851. Epub 2016 Oct 4.

6.

Cytokeratin 5-Positive Cells Represent a Therapy Resistant subpopulation in Epithelial Ovarian Cancer.

Corr BR, Finlay-Schultz J, Rosen RB, Qamar L, Post MD, Behbakht K, Spillman MA, Sartorius CA.

Int J Gynecol Cancer. 2015 Nov;25(9):1565-73. doi: 10.1097/IGC.0000000000000553.

7.

Steroid hormones, steroid receptors, and breast cancer stem cells.

Finlay-Schultz J, Sartorius CA.

J Mammary Gland Biol Neoplasia. 2015 Jun;20(1-2):39-50. doi: 10.1007/s10911-015-9340-5. Epub 2015 Aug 12. Review.

8.

Progesterone downregulation of miR-141 contributes to expansion of stem-like breast cancer cells through maintenance of progesterone receptor and Stat5a.

Finlay-Schultz J, Cittelly DM, Hendricks P, Patel P, Kabos P, Jacobsen BM, Richer JK, Sartorius CA.

Oncogene. 2015 Jul;34(28):3676-87. doi: 10.1038/onc.2014.298. Epub 2014 Sep 22.

9.

Patient-derived luminal breast cancer xenografts retain hormone receptor heterogeneity and help define unique estrogen-dependent gene signatures.

Kabos P, Finlay-Schultz J, Li C, Kline E, Finlayson C, Wisell J, Manuel CA, Edgerton SM, Harrell JC, Elias A, Sartorius CA.

Breast Cancer Res Treat. 2012 Sep;135(2):415-32. doi: 10.1007/s10549-012-2164-8. Epub 2012 Jul 24.

10.

Progestin suppression of miR-29 potentiates dedifferentiation of breast cancer cells via KLF4.

Cittelly DM, Finlay-Schultz J, Howe EN, Spoelstra NS, Axlund SD, Hendricks P, Jacobsen BM, Sartorius CA, Richer JK.

Oncogene. 2013 May 16;32(20):2555-64. doi: 10.1038/onc.2012.275. Epub 2012 Jul 2.

11.

Promoter methylation and tissue-specific transcription of the α7 nicotinic receptor gene, CHRNA7.

Canastar A, Logel J, Graw S, Finlay-Schultz J, Osborne C, Palionyte M, Drebing C, Plehaty M, Wilson L, Eyeson R, Leonard S.

J Mol Neurosci. 2012 Jun;47(2):389-400. doi: 10.1007/s12031-011-9663-7. Epub 2011 Nov 4.

PMID:
22052086
12.

Transcriptional repression of the α7 nicotinic acetylcholine receptor subunit gene (CHRNA7) by activating protein-2α (AP-2α).

Finlay-Schultz J, Canastar A, Short M, El Gazzar M, Coughlan C, Leonard S.

J Biol Chem. 2011 Dec 9;286(49):42123-32. doi: 10.1074/jbc.M111.276014. Epub 2011 Oct 6.

Supplemental Content

Loading ...
Support Center